Steven Kafka
Chief Executive Officer at DA32 LIFE SCIENCE TECH ACQUISITION CORP.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Rosana Kapeller-Libermann | M | 60 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | 5 years |
Seth Tasker | M | 45 | 16 years | |
Peyton Greenside | M | - |
BigHat Biosciences, Inc.
BigHat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology BigHat Biosciences, Inc. operates as an early-stage biotechnology company. The firm focuses on designing antibodies and other therapeutic proteins using artificial intelligence and machine learning techniques. The company was founded by Mark DePristo and Peyton Greenside in 2019 and is headquartered in San Carlos, CA. | 5 years |
Sarah Larson | F | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California.
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | 11 years |
Mark DePristo | M | - |
BigHat Biosciences, Inc.
BigHat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology BigHat Biosciences, Inc. operates as an early-stage biotechnology company. The firm focuses on designing antibodies and other therapeutic proteins using artificial intelligence and machine learning techniques. The company was founded by Mark DePristo and Peyton Greenside in 2019 and is headquartered in San Carlos, CA. | 5 years |
Kira Nelson | F | 55 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | - |
Jonathan Ang | M | - |
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Sunbird Bio, Inc. is a biotech company based in Cambridge, MA. Sunbird Bio is developing protein-based diagnostic tests to empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The private company's apex technology is the first test to demonstrate the ability to detect the presence of Alzheimer's disease with a blood test. Sunbird Bio is addressing diagnostic testing to enhance patient care. The company was founded by Nicholas Ho, Carine Lim, and Huilin Shao. The CEO is John P. McDonough. | - |
R. Alan B. Ezekowitz | M | 70 |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | 5 years |
Kyle Kuvalanka | M | 56 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | 1 years |
Jonathan Faerber | M | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 6 years |
E. Hrusovsky | M | 63 | 3 years | |
Jay Parrish | M | 49 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | 5 years |
Andrew Harrison | M | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 3 years |
Konstantin Fiedler | M | 58 | 8 years | |
Josephine Kahn | F | - |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | 5 years |
Huilin Shao | M | - |
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Sunbird Bio, Inc. is a biotech company based in Cambridge, MA. Sunbird Bio is developing protein-based diagnostic tests to empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The private company's apex technology is the first test to demonstrate the ability to detect the presence of Alzheimer's disease with a blood test. Sunbird Bio is addressing diagnostic testing to enhance patient care. The company was founded by Nicholas Ho, Carine Lim, and Huilin Shao. The CEO is John P. McDonough. | - |
Nick Smith | M | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 2 years |
Matthew Navarro | M | - |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | - |
Nicholas Ho | M | - |
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Sunbird Bio, Inc. is a biotech company based in Cambridge, MA. Sunbird Bio is developing protein-based diagnostic tests to empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The private company's apex technology is the first test to demonstrate the ability to detect the presence of Alzheimer's disease with a blood test. Sunbird Bio is addressing diagnostic testing to enhance patient care. The company was founded by Nicholas Ho, Carine Lim, and Huilin Shao. The CEO is John P. McDonough. | - |
Nina Labatt | F | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 3 years |
Angela Lai | F | - | 3 years | |
Carine Lim | M | - |
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Sunbird Bio, Inc. is a biotech company based in Cambridge, MA. Sunbird Bio is developing protein-based diagnostic tests to empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The private company's apex technology is the first test to demonstrate the ability to detect the presence of Alzheimer's disease with a blood test. Sunbird Bio is addressing diagnostic testing to enhance patient care. The company was founded by Nicholas Ho, Carine Lim, and Huilin Shao. The CEO is John P. McDonough. | - |
Nicolas Roelofs | M | 66 | 3 years | |
Stanley Lapidus | M | 75 |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA.
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Sunbird Bio, Inc. is a biotech company based in Cambridge, MA. Sunbird Bio is developing protein-based diagnostic tests to empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The private company's apex technology is the first test to demonstrate the ability to detect the presence of Alzheimer's disease with a blood test. Sunbird Bio is addressing diagnostic testing to enhance patient care. The company was founded by Nicholas Ho, Carine Lim, and Huilin Shao. The CEO is John P. McDonough. | - |
James Scibetta | M | 59 |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | 3 years |
Anthony Evnin | M | 83 | 18 years | |
Chris Wolfe | M | 44 | 3 years | |
Douglas Ingram | M | 61 | 5 years | |
Marvin H. Caruthers | M | 84 |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | 6 years |
John McDonough | M | 65 |
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Sunbird Bio, Inc. is a biotech company based in Cambridge, MA. Sunbird Bio is developing protein-based diagnostic tests to empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The private company's apex technology is the first test to demonstrate the ability to detect the presence of Alzheimer's disease with a blood test. Sunbird Bio is addressing diagnostic testing to enhance patient care. The company was founded by Nicholas Ho, Carine Lim, and Huilin Shao. The CEO is John P. McDonough. | - |
Linda Hill | M | 67 | 6 years | |
Alexandra Cantley | M | - |
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Sunbird Bio, Inc. is a biotech company based in Cambridge, MA. Sunbird Bio is developing protein-based diagnostic tests to empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The private company's apex technology is the first test to demonstrate the ability to detect the presence of Alzheimer's disease with a blood test. Sunbird Bio is addressing diagnostic testing to enhance patient care. The company was founded by Nicholas Ho, Carine Lim, and Huilin Shao. The CEO is John P. McDonough. | - |
George Zachary | M | 58 |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | - |
Ainhoa Maiz | F | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 2 years |
Amy Schulman | F | 63 |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | - |
Francisco Gimenez | M | - |
BigHat Biosciences, Inc.
BigHat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology BigHat Biosciences, Inc. operates as an early-stage biotechnology company. The firm focuses on designing antibodies and other therapeutic proteins using artificial intelligence and machine learning techniques. The company was founded by Mark DePristo and Peyton Greenside in 2019 and is headquartered in San Carlos, CA. | - |
Kenzo Fong | M | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Vineeta Agarwala | M | - |
BigHat Biosciences, Inc.
BigHat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology BigHat Biosciences, Inc. operates as an early-stage biotechnology company. The firm focuses on designing antibodies and other therapeutic proteins using artificial intelligence and machine learning techniques. The company was founded by Mark DePristo and Peyton Greenside in 2019 and is headquartered in San Carlos, CA. | - |
Pam Stetkiewicz | M | - |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | 2 years |
Wesley Tillu | M | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 3 years |
Ying Min Wang | F | - |
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Sunbird Bio, Inc. is a biotech company based in Cambridge, MA. Sunbird Bio is developing protein-based diagnostic tests to empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The private company's apex technology is the first test to demonstrate the ability to detect the presence of Alzheimer's disease with a blood test. Sunbird Bio is addressing diagnostic testing to enhance patient care. The company was founded by Nicholas Ho, Carine Lim, and Huilin Shao. The CEO is John P. McDonough. | - |
Aaron arvey | M | - |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | 5 years |
Harshitha Gamahewage | M | - |
BigHat Biosciences, Inc.
BigHat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology BigHat Biosciences, Inc. operates as an early-stage biotechnology company. The firm focuses on designing antibodies and other therapeutic proteins using artificial intelligence and machine learning techniques. The company was founded by Mark DePristo and Peyton Greenside in 2019 and is headquartered in San Carlos, CA. | - |
Kimberly Shih | F | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Alice Cheung | F | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 4 years |
Seema Bhan | F | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Keith Crandell | M | 63 | 3 years | |
Robert Chess | M | 66 |
BigHat Biosciences, Inc.
BigHat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology BigHat Biosciences, Inc. operates as an early-stage biotechnology company. The firm focuses on designing antibodies and other therapeutic proteins using artificial intelligence and machine learning techniques. The company was founded by Mark DePristo and Peyton Greenside in 2019 and is headquartered in San Carlos, CA. | 2 years |
Kristina Burow | F | 50 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | - |
Peter Hutt | M | 89 |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | - |
Krishna Yeshwant | M | 46 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | - |
Andrew Conrad | M | 60 |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Robert Gunderson | M | 72 |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Michael Pellini | M | 58 |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | 7 years |
David Friedberg | M | 43 |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Ittai Harel | M | 56 |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | - |
William Maris | M | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Christoph H. Westphal | M | 56 |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | - |
Jessica Atkinson | F | - |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | 2 years |
Theresia Gouw | F | 56 |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | - |
Jeffrey Hatfield | M | 66 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | 2 years |
Daniel Janney | M | 58 |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | - |
Reid Huber | M | 52 |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | 6 years |
Jason Hafler | M | 42 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | - |
Robert Langer | M | 75 |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | - |
Scott Biller | M | 68 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | 3 years |
Andrew ElBardissi | M | 42 | 3 years | |
Jeb Keiper | M | - |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | 5 years |
Andy Conrad | M | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Carlos Solorzano | M | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gerald Quirk | M | 56 | 6 years | |
David Daly | M | 62 |
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | 6 years |
Britton A. Russell | M | 35 |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | 2 years |
Mike Pellini | M | - | 7 years | |
Matthew Franklin | M | 50 |
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA.
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | 6 years |
Troy Cox | M | 60 | 2 years | |
Michael Dougherty | M | 66 | 2 years | |
Dipchand Nishar | M | 55 | 2 years | |
Joshua Stahl | M | 38 |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | 7 years |
Andrea N. Flynn | M | - |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | 1 years |
Jason Ryan | M | 49 |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | - |
Martin Babler | M | 59 | 6 years | |
Susan T. Hager | F | - | 5 years | |
Patrick Lee | M | 67 | 7 years | |
Mark Levin | M | 73 | 4 years | |
Mara Aspinall | F | 61 | 2 years | |
Eric S. Lander | M | 67 | 10 years | |
David Schenkein | M | 66 | 7 years | |
John Hector McArthur | M | 90 | 8 years | |
Scott Kapnick | M | - | 8 years | |
Ian Smith | M | 58 | 11 years | |
GEORGE XU | M | - |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | - |
Andrea DiMella | F | - |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | 4 years |
Herm Rosenman | M | 76 | 4 years | |
Timur Yusufzai | M | - |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | 1 years |
Christopher Dinsmore | M | 58 |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | 1 years |
Colleen Wilson | F | 47 | 2 years | |
Tamyra A. Toole | F | - | 9 years | |
James Tananbaum | M | 59 | 6 years | |
Paul Melone | M | - | 15 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Steven Kafka
- Personal Network